FDA label
What is Mavyret used for?
Mavyret contains glecaprevir and pibrentasvir. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with acute or chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A).”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Mavyret?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Mavyret, pellet
Indications and Usage, quoted from the label by AbbVie Inc. (NDA215110). Cross-references to other label sections are left out.
MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with acute or chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A).
MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor (PI), but not both.
Source: DailyMed label, set id 7bf99777-0401-9095-8645-16c6e907fcc0, version 201, effective June 25, 2025. NDC 0074-2600, one of 1 listing for this product.
Questions
What is Mavyret used for?
The FDA label says: “MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with acute or chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A).”
What drug class is Mavyret?
FDA lists glecaprevir and pibrentasvir in the Hepatitis C Virus NS3/4A Protease Inhibitor and Hepatitis C Virus NS5A Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.